As GLP-1s boom, dietician startups Berry Street, Fay each nab $50M rounds
For decades, the U.S. healthcare system has struggled to address the diet-related chronic illnesses affecting nearly half of all adults. That changed in recent years with the discovery of Ozempic and other GLP-1 drugs that help people lose weight....